港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

撥康視雲-B

4.590

+0.0200.44%

成交量：18.50萬

成交額：85.48萬

市值：38.60億

市盈率：-2.83

高：4.710

開：4.570

低：4.560

收：4.570

52周最高：9.740

52周最低：3.940

股本：8.41億

香港流通股本：8.41億

量比：0.41

換手率：0.02%

股息：- -

股息率：- -

每股收益(LYR):-1.620

淨資產收益率：--

總資產收益率：-44.38%

市淨率：-1.50

市盈率(LYR):-2.83

市銷率: 48.51

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

撥康視雲-B

交易所：

SEHK

成立時間：

2015

員工人數：

60

公司地址：

8921 Research Drive,Irvine,California,United States

官網：

http://cloudbreakpharma.com

郵編：

92618

電話：

- -

傳真：

- -

簡介：

Cloudbreak Pharma Inc是一家臨床階段的眼科生物技術公司，從事開發各種治療方法。該公司專註於眼科療法的內部發現、開發和商業化。該公司擁有兩款核心產品 CBT-001和CBT-009，均為自主研發。該公司的核心產品CBT-001用於治療翼狀胬肉（一種良性增生性眼表疾病），已在美國和中國啟動III期多區域臨床試驗（MRCT）。該公司的核心產品CBT-009用於治療青少年近視（5至19歲兒童和青少年的近視），已完成I/II期臨床試驗。該公司的其他候選藥物處於相對早期的開發階段，包括另外兩種臨床階段候選藥物，即CBT-006和CBT-004，以及四種臨床前階段候選藥物，即CBT-007、CBT-199、CBT-145和CBT-011。

董事

名稱

職位

NI Jinsong

董事會主席，執行董事

Van Son DINH

執行董事

YANG Rong

執行董事

賴顯榮

獨立非執行董事，薪酬委員會委員，提名委員會主席，審核委員會委員

聶四江

獨立非執行董事，薪酬委員會主席，提名委員會委員，審核委員會委員

馬遙豪

獨立非執行董事，薪酬委員會委員，提名委員會委員，審核委員會主席

LI Jun Zhi

非執行董事，薪酬委員會委員，提名委員會委員，審核委員會委員

曹旭

非執行董事

夏志東

非執行董事

股東

名稱

職位

NI Jinsong

首席執行官

陳清珠

首席財務官

馮雅芳

財務總監，公司秘書

Elizabeth Sharon CAPAN

首席合規官，首席專利官

Van Son DINH

首席營運官

YANG Rong

首席科學官

Abu P ABRAHAM

首席醫療官

FANG Wenkui Ken

首席創新官

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02592/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02592","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02592\",,,,,undefined,":{"symbol":"02592","market":"HK","secType":"STK","nameCN":"撥康視雲-B","latestPrice":4.59,"timestamp":1761293295060,"preClose":4.57,"halted":0,"volume":185000,"delay":0,"floatShares":841000000,"shares":841000000,"eps":-1.6202282810545372,"marketStatus":"未開盤","change":0.02,"latestTime":"10-24 16:08:15","open":4.57,"high":4.71,"low":4.56,"amount":854835,"amplitude":0.032823,"askPrice":4.64,"askSize":500,"bidPrice":4.59,"bidSize":3000,"shortable":0,"etf":0,"ttmEps":-1.3087388598379188,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1761528600000},"marketStatusCode":0,"adr":0,"listingDate":1751472000000,"exchange":"SEHK","adjPreClose":4.57,"openAndCloseTimeList":[[1761269400000,1761278400000],[1761282000000,1761292800000]],"volumeRatio":0.4097452935206749,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02592\",,,,,undefined,":{"symbol":"02592","floatShares":841000000,"roa":"-44.38%","roe":"--","lyrEps":-1.620228,"volumeRatio":0.4097452935206749,"shares":841000000,"dividePrice":0,"high":4.71,"amplitude":0.032823,"preClose":4.57,"low":4.56,"week52Low":3.94,"pbRate":"-1.50","psRate":"48.51","week52High":9.74,"institutionHeld":0,"latestPrice":4.59,"committee":0.714286,"eps":-1.6202282810545372,"divideRate":0,"volume":185000,"delay":0,"ttmEps":-1.3087388598379188,"open":4.57,"prevYearClose":10.1,"prevWeekClose":4.59,"prevMonthClose":4.51,"prevQuarterClose":4.51,"fiveDayClose":4.78,"twentyDayClose":4.81,"sixtyDayClose":5.57},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02592\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"02592","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02592\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02592\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02592\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02592","date":"2025-10-24","current":-3.507166,"percent":0.253165,"low":-13.478827,"twenty":-12.25273,"median":-6.279578,"eighty":-5.580054,"high":-5.348116,"avg":-7.955567,"sd":3.022891,"marketCap":3850518291},"quantilePoints":[{"date":"2025-07-04","current":-6.317277,"twenty":-6.610502,"median":-6.500542,"eighty":-6.390583,"marketCap":4915912241},{"date":"2025-07-11","current":-6.166376,"twenty":-6.470405,"median":-6.317277,"eighty":-6.263403,"marketCap":4798467239},{"date":"2025-07-18","current":-6.350904,"twenty":-6.498689,"median":-6.350281,"eighty":-6.263403,"marketCap":4941079027},{"date":"2025-07-25","current":-6.080141,"twenty":-6.48004,"median":-6.306537,"eighty":-6.134066,"marketCap":4731355809},{"date":"2025-08-01","current":-5.497985,"twenty":-6.418895,"median":-6.177156,"eighty":-6.011186,"marketCap":4278353657},{"date":"2025-08-08","current":-5.49809,"twenty":-6.350655,"median":-6.13405,"eighty":-5.65539,"marketCap":4278353657},{"date":"2025-08-15","current":-5.725306,"twenty":-6.343182,"median":-6.058573,"eighty":-5.554248,"marketCap":4446132232},{"date":"2025-08-22","current":-5.53457,"twenty":-6.315129,"median":-6.004685,"eighty":-5.554248,"marketCap":4286742586},{"date":"2025-08-29","current":-5.503941,"twenty":-6.295753,"median":-5.870846,"eighty":-5.538055,"marketCap":4253186871},{"date":"2025-09-05","current":-5.413205,"twenty":-6.239682,"median":-5.742284,"eighty":-5.49926,"marketCap":4186075441},{"date":"2025-09-12","current":-12.640894,"twenty":-6.350655,"median":-5.870846,"eighty":-5.508123,"marketCap":4118964011},{"date":"2025-09-19","current":-12.711577,"twenty":-6.612702,"median":-6.004685,"eighty":-5.525012,"marketCap":4135741868},{"date":"2025-09-26","current":-11.804503,"twenty":-12.358821,"median":-6.058573,"eighty":-5.527436,"marketCap":3842129362},{"date":"2025-10-03","current":-6.439136,"twenty":-12.191113,"median":-6.134046,"eighty":-5.53457,"marketCap":2096453591},{"date":"2025-10-10","current":-5.988337,"twenty":-11.881825,"median":-6.134089,"eighty":-5.548508,"marketCap":1949083838},{"date":"2025-10-17","current":-12.3346,"twenty":-12.21981,"median":-6.187936,"eighty":-5.561014,"marketCap":4009907937},{"date":"2025-10-24","current":-11.844495,"twenty":-12.25273,"median":-6.279578,"eighty":-5.580054,"marketCap":3850518291}],"updateTime":1761509226144},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1934212103,"yearFounded":2015,"employeeNum":60,"address":"8921 Research Drive,Irvine,California,United States","zipCode":"92618"},"stockCompanyDetail":{"websiteUrl":"http://cloudbreakpharma.com","stockEarnings":[{"period":"1week","weight":-0.0397},{"period":"1month","weight":-0.0457},{"period":"3month","weight":-0.1862},{"period":"6month","weight":-0.5455},{"period":"ytd","weight":-0.5455}],"compareEarnings":[{"period":"1week","weight":0.0362},{"period":"1month","weight":-0.0135},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.1901},{"period":"1year","weight":0.2768},{"period":"ytd","weight":0.3041}],"compareStock":{"symbol":"HSI","name":"恆生指數"},"description":"Cloudbreak Pharma Inc是一家臨床階段的眼科生物技術公司，從事開發各種治療方法。該公司專註於眼科療法的內部發現、開發和商業化。該公司擁有兩款核心產品 CBT-001和CBT-009，均為自主研發。該公司的核心產品CBT-001用於治療翼狀胬肉（一種良性增生性眼表疾病），已在美國和中國啟動III期多區域臨床試驗（MRCT）。該公司的核心產品CBT-009用於治療青少年近視（5至19歲兒童和青少年的近視），已完成I/II期臨床試驗。該公司的其他候選藥物處於相對早期的開發階段，包括另外兩種臨床階段候選藥物，即CBT-006和CBT-004，以及四種臨床前階段候選藥物，即CBT-007、CBT-199、CBT-145和CBT-011。","exchange":"SEHK","name":"撥康視雲-B","nameEN":"CLOUDBREAK-B"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"02592\",market:\"HK\",,,undefined,":{"directors":[{"name":"NI Jinsong","position":"董事會主席，執行董事"},{"name":"Van Son DINH","position":"執行董事"},{"name":"YANG Rong","position":"執行董事"},{"name":"賴顯榮","position":"獨立非執行董事，薪酬委員會委員，提名委員會主席，審核委員會委員"},{"name":"聶四江","position":"獨立非執行董事，薪酬委員會主席，提名委員會委員，審核委員會委員"},{"name":"馬遙豪","position":"獨立非執行董事，薪酬委員會委員，提名委員會委員，審核委員會主席"},{"name":"LI Jun Zhi","position":"非執行董事，薪酬委員會委員，提名委員會委員，審核委員會委員"},{"name":"曹旭","position":"非執行董事"},{"name":"夏志東","position":"非執行董事"}],"executives":[{"name":"NI Jinsong","position":"首席執行官"},{"name":"陳清珠","position":"首席財務官"},{"name":"馮雅芳","position":"財務總監，公司秘書"},{"name":"Elizabeth Sharon CAPAN","position":"首席合規官，首席專利官"},{"name":"Van Son DINH","position":"首席營運官"},{"name":"YANG Rong","position":"首席科學官"},{"name":"Abu P ABRAHAM","position":"首席醫療官"},{"name":"FANG Wenkui Ken","position":"首席創新官"}]}}}